Ad is loading...
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
SVBCX
Price
$28.88
Change
-$0.24 (-0.82%)
Updated
Nov 15 closing price
Ad is loading...

RLEFX vs SVBCX

Header iconRLEFX vs SVBCX Comparison
Open Charts RLEFX vs SVBCXBanner chart's image
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
JHancock Balanced C
Price$28.88
Change-$0.24 (-0.82%)
VolumeN/A
CapitalizationN/A
RLEFX vs SVBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLEFX vs. SVBCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLEFX is a StrongBuy and SVBCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. SVBCX (5.53B). RLEFX pays higher dividends than SVBCX: RLEFX (2.42) vs SVBCX (0.68). RLEFX was incepted earlier than SVBCX: RLEFX (9 years) vs SVBCX (26 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. SVBCX (62.00). RLEFX has a lower initial minimum investment than SVBCX: RLEFX (250) vs SVBCX (1000). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. SVBCX (17.58). SVBCX return over 5 years is better than : 40.58 vs. RLEFX (35.95).
RLEFXSVBCXRLEFX / SVBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years26 years-
Gain YTD14.21111.001129%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets236B5.53B4,270%
Annual Yield % from dividends2.420.68354%
Returns for 1 year21.0917.58120%
Returns for 3 years10.957.71142%
Returns for 5 years35.9540.5889%
Returns for 10 yearsN/A57.01-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology